PMID: 15665799
You should contact your GP or diabetes specialist nurse if: Weakness is severe, persistent, or progressively worsening You experience recurrent episodes of hypoglycaemia (blood glucose below 4 mmol/L) [13] Weakness is accompanied by chest pain, shortness of breath, or palpitations You have significant muscle weakness affecting mobility or daily activities Gastrointestinal symptoms (nausea, vomiting, diarrhoea) are severe or prolonged, leading to dehydration You notice unexplained weight loss beyond what is expected with treatment You develop symptoms of pancreatitis (severe, persistent abdominal pain radiating to the back) You experience right upper quadrant pain, fever or jaundice (possible gallbladder issues) You notice new or sudden changes in your vision You have reduced urine output or confusion (possible dehydration or kidney problems) Contact NHS 111 for urgent but non-life-threatening concerns, or seek emergency care (call 999 or attend A&E) if: You experience symptoms of severe hypoglycaemia with confusion, loss of consciousness, or seizures You have signs of severe dehydration (extreme dizziness, reduced urine output, rapid heartbeat) You develop symptoms suggestive of diabetic ketoacidosis (though rare with GLP-1 receptor agonists like Ozempic), such as abdominal pain, vomiting, rapid breathing, and ketones in blood or urine [23] [24] Your healthcare provider can conduct a thorough assessment, including blood tests to evaluate glucose control, electrolyte balance, kidney function, and thyroid status
She oversees all IV therapy protocols and reviews all health content published on instadrip.com to ensure medical accuracy.
MAIN COMPONENTS: L-carnitine - promotes energy production through the breakdown of subcutaneous fat, increases endurance during physical activity, prevents the accumulation of lactic acid in muscles
If you choose Concierge Weight loss injections, we will also review how to properly administer Concierge Weight loss in the fatty tissue areas of your body so you can continue your maintenance treatments comfortably and safely at home
Unlike Western populations where severe obesity is common, it confirmed that the once-weekly 2.4mg semaglutide regimen is also an effective and safe treatment option for Koreans and East Asians, who have a higher proportion of obese patients with relatively lower BMIs. As the study applied the obesity criteria used in actual clinical practice, it will serve as important evidence for establishing clinical guidelines and insurance policies, Professor Lim added
-(1).png?sfvrsn=c236e848_3)
